90
Participants
Start Date
January 1, 2017
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Colchicine
Randomized to colchicine 0.6 mg x 2/day
Dapsone
Randomized to dapsone 150 mg/day
Azathioprine
Randomized to azathioprine 2 mg/kg/day
COMPLETED
Hospital for Special Surgery, New York
COMPLETED
Northwell Health, Lake Success
COMPLETED
Penn State Hershey Medical Center, Hershey
RECRUITING
University of Pennsylvania, Philadelphia
RECRUITING
University of Virginia, Charlottesville
RECRUITING
Vanderbilt University, Nashville
COMPLETED
Mayo Clinic, Rochester
RECRUITING
UT Southwestern Medical Center, Dallas
RECRUITING
University of Kansas Medical Center, Kansas City
COMPLETED
Cleveland Clinic, Cleveland
COMPLETED
University of Utah, Salt Lake City
RECRUITING
St. Joseph's Healthcare, Hamilton
RECRUITING
University of Toronto Mount Sinai Hospital, Toronto
COMPLETED
Boston University School of Medicine, Boston
RECRUITING
McGill University Health Centre, Montreal
COMPLETED
Tohoku Medical and Pharmaceutical University Hospital, Kyoto
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
National Center for Advancing Translational Sciences (NCATS)
NIH
Office of Rare Diseases (ORD)
NIH
University of Pennsylvania
OTHER